Why an Israeli company is developing an oral Covid-19 vaccine | Malay Mail

대한민국 뉴스 뉴스

Why an Israeli company is developing an oral Covid-19 vaccine | Malay Mail
대한민국 최근 뉴스,대한민국 헤드 라인

JERUSALEM, Aug 2 — Imagine a Covid-19 vaccine that came as a pill: no needles, no medical professionals required to administer it, potentially delivered directly to people’s homes.  Israeli pharmaceutical Oramed is attempting to accomplish just that, and is poised to start its first...

  • 📰 malaymail
  • ⏱ Reading Time:
  • 39 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 86%

JERUSALEM, Aug 2 — Imagine a Covid-19 vaccine that came as a pill: no needles, no medical professionals required to administer it, potentially delivered directly to people’s homes.

Oral vaccines are particularly attractive for the developing world, because they reduce the logistical burden of immunisation campaigns, said Kidron. “In order for the vaccine to really work well, we need as many people to take it as possible,” said Kidron.Challenges for oral delivery Oramed, which was founded in 2006, believes it has overcome the technical hurdles by designing a capsule that survives the highly acidic environment of the gut.

It also releases molecules called protease inhibitors that stop enzymes in the small intestine from breaking down the insulin, and an absorption enhancer to help the insulin cross into the bloodstream. These mimic three key structures of the pathogen: the spike protein, the envelope protein and the membrane protein.

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

malaymail /  🏆 1. in KR
 

대한민국 최근 뉴스, 대한민국 헤드 라인



Render Time: 2025-01-15 20:14:34